Date

Tuesday, 3 September 2024 - Friday, 6 September 2024

Location

European Medicines Agency, Amsterdam, the Netherlands
 
The Paediatric Committee (PDCO) is the committee that is responsible for assessing the content of paediatric investigation plans, which describe how a medicine should be studied in children, as well as waivers and deferrals.

Documents

In the context of the digitalisation of the Agency’s activities and further to the launch of Paediatric submissions in IRIS, the agenda is presented in a new format, with the aim to facilitate the analysis of the data. 

We would like to invite you to share with us feedback on your experience with the new format to PDCOSecretariat@ema.europa.eu 

Share this page